ID
35684
Description
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contains the Study Medication And Compliance Record form. It has to be filled in for each Visit. It also cntains the Dose reduction due to AE form. It has to be filled in for Week 12-48 and Follow-up.
Mots-clés
Versions (1)
- 15/03/2019 15/03/2019 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
15 mars 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
Description
Study Medication And Compliance Record
Alias
- UMLS CUI-1
- C2734539
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1321605
Description
Week Number
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0439230
- UMLS CUI [1,2]
- C0237753
Description
Dose Level
Type de données
integer
Alias
- UMLS CUI [1]
- C0178602
Description
day month year
Type de données
date
Alias
- UMLS CUI [1]
- C3173309
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Description
Number of tablets dispensed
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Description
Number of tablets returned
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Description
Dose Reductions Due to Adverse Experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Description
Week
Type de données
integer
Alias
- UMLS CUI [1]
- C0439230
Description
Dose Level
Type de données
integer
Alias
- UMLS CUI [1]
- C0178602
Description
day month year
Type de données
date
Alias
- UMLS CUI [1]
- C3173309
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Description
Number of tablets dispensed
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Description
Number of tablets returned
Type de données
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Similar models
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1321605 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Aucun commentaire